Interleukin-3 and Granulocyte-Macrophage Colony-stimulating Factor Inhibits Tumor Necrosis Factor (TNF)-α-induced Osteoclast Differentiation by Down-regulation of Expression of TNF Receptors 1 and 2*

Osteoclasts, the multinucleated cells that resorb bone, differentiate from hemopoietic precursors of monocyte/macrophage lineage, which also give rise to macrophages or dendritic cells. In this study we investigated the mechanism by which interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) inhibit tumor necrosis factor (TNF)-α-induced osteoclast differentiation in mouse osteoclast precursors. We show here that both IL-3 and GM-CSF potently inhibits TNF-α-induced osteoclast differentiation by direct action on osteoclast precursors. The inhibitory effect of IL-3 and GM-CSF on osteoclast differentiation was completely neutralized by anti-IL-3 and anti-GM-CSF antibodies, respectively. In addition, the inhibitory effect of IL-3 and GM-CSF on TNF-α-induced osteoclast differentiation was irreversible. In osteoclast precursors, IL-3 and GM-CSF inhibited c-Fms expression post-transcriptionally. Interestingly, IL-3 and GM-CSF down-regulated both mRNA and surface expression of TNF receptor 1 (TNFR1) and TNFR2. Furthermore, cells in the presence of IL-3 and GM-CSF showed high expression of macrophage antigen CD11b, and low expression of dendritic cells antigen CD11c and prolong exposure of osteoclast precursors to GM-CSF increased the CD11c expression compare with IL-3. In summary, we provide the first evidence that IL-3 and GM-CSF block TNF-α-induced osteoclast differentiation by down-regulation of mRNA and surface expression of TNFR1 and TNFR2.

• Publication year

  2005

• Venue

  Journal of Biological Chemistry

• Publication date

  2005-01-14

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1074/JBC.M410828200PMID 15653694
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Osteoimmunology: interactions of the immune and skeletal systems.

  2004cited by this paper
• Breast cancer cells induce osteoclast formation by stimulating host IL‐11 production and downregulating granulocyte/macrophage colony‐stimulating factor

  2004cited by this paper
• Gene array identification of osteoclast genes: Differential inhibition of osteoclastogenesis by cyclosporin A and granulocyte macrophage colony stimulating factor

  2004cited by this paper
• IL-3 Acts Directly on Osteoclast Precursors and Irreversibly Inhibits Receptor Activator of NF-κB Ligand-Induced Osteoclast Differentiation by Diverting the Cells to Macrophage Lineage1

  2003cited by this paper
• TNFα Potently Activates Osteoclasts, through a Direct Action Independent of and Strongly Synergistic with RANKL.

  2002cited by this paper
• Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture.

  2001cited by this paper
• Bifurcation of osteoclasts and dendritic cells from common progenitors.

  2001cited by this paper
• Up-regulation of TNF-producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo

  2001cited by this paper
• Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis.

  2000cited by this paper
• Tumor Necrosis Factor-α Induces Differentiation of and Bone Resorption by Osteoclasts*

  2000cited by this paper
• RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism.

  2000cited by this paper
• TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.

  2000cited by this paper
• Bone resorption by osteoclasts.

  2000cited by this paper
• A role for TGFbeta(1) in osteoclast differentiation and survival.

  2000cited by this paper
• Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha.

  2000cited by this paper
• Recent advances in the molecular basis of TNF signal transduction.

  1999cited by this paper
• Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.

  1999cited by this paper
• OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

  1999cited by this paper
• Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines.

  1999cited by this paper
• Tumor necrosis factor-alpha mediates orthopedic implant osteolysis.

  1999cited by this paper
• Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.

  1999cited by this paper
• RANK is essential for osteoclast and lymph node development.

  1999cited by this paper
• Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells.

  1999cited by this paper
• Interleukin‐3 and granulocyte–macrophage colony‐stimulating factor enhance the generation and function of dendritic cells

  1999cited by this paper
• Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: synergistic activation of differentiation, cell spreading, and fusion.

  1999cited by this paper
• Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

  1998cited by this paper
• IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis.

  1998cited by this paper
• Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

  1998cited by this paper
• Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor.

  1998cited by this paper
• RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.

  1998cited by this paper
• Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor.

  1997cited by this paper
• A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

  1997cited by this paper
• TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells*

  1997cited by this paper
• The Functional Block of TNF but Not of IL‐6 Prevents Bone Loss in Ovariectomized Mice

  1997cited by this paper
• Interleukin-18 (Interferon-γ–inducing Factor) Is Produced by Osteoblasts and Acts Via Granulocyte/Macrophage Colony-stimulating Factor and Not Via Interferon-γ to Inhibit Osteoclast Formation

  1997cited by this paper
• The NF-kappa B and I kappa B proteins: new discoveries and insights.

  1996cited by this paper
• Interleukin-3 cooperates with tumor necrosis factor alpha for the development of human dendritic/Langerhans cells from cord blood CD34+ hematopoietic progenitor cells.

  1996cited by this paper
• Role of cytokines in rheumatoid arthritis.

  1996cited by this paper
• Bacterially induced bone destruction: mechanisms and misconceptions

  1996cited by this paper
• Estrogen Deficiency Increases the Ability of Stromal Cells to Support Murine Osteoclastogenesis via an Interleukin-1and Tumor Necrosis Factor-mediated Stimulation of Macrophage Colony-stimulating Factor Production*

  1996cited by this paper
• Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.

  1995cited by this paper
• Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.

  1994cited by this paper
• Granulocyte-macrophage colony stimulating factor suppresses lipopolysaccharide-induced osteoclast-like cell formation in mouse bone marrow cultures.

  1994cited by this paper
• Tumor necrosis factors alpha and beta can stimulate bone resorption in cultured mouse calvariae by a prostaglandin-independent mechanism.

  1993cited by this paper
• Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors.

  1993cited by this paper
• Tumor necrosis factor alpha cooperates with interleukin 3 in the recruitment of a primitive subset of human CD34+ progenitors

  1993cited by this paper
• Two TNF receptors.

  1992cited by this paper
• Two distinct effects of recombinant human tumor necrosis factor-alpha on osteoclast development and subsequent resorption of mineralized matrix.

  1991cited by this paper
• Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.

  1991cited by this paper
• Expression of the M-CSF receptor is controlled posttranscriptionally by the dominant actions of GM-CSF or multi-CSF.

  1990cited by this paper
• The effect of hemopoietic growth factors on the generation of osteoclast-like cells in mouse bone marrow cultures.

  1990cited by this paper
• Effects of interleukin 3 and of granulocyte‐macrophage and macrophage colony stimulating factors on osteoclast differentiation from mouse hemopoietic tissue

  1990cited by this paper
• The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

  1990cited by this paper
• Tumor necrosis factor alpha and interleukin-1 stimulate bone resorption in vivo as measured by urinary [3H]tetracycline excretion from prelabeled mice.

  1988cited by this paper
• Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.

  1988cited by this paper
• Human macrophage colony‐stimulating factor inhibits bone resorption by osteoclasts disaggregated from rat bone

  1988cited by this paper
• Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption.

  1987cited by this paper
• Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors

  1986cited by this paper

• Cell signaling and transcriptional regulation of osteoclast lineage commitment, differentiation, bone resorption and diseases

  2026cites this paper
• Priming of mouse pre-osteoblasts with Interleukin-3 attenuates TNF-α-induced-inhibition of osteoblast differentiation

  2025cites this paper
• Emerging Roles of Eosinophils in Bone

  2025cites this paper
• The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review

  2023cites this paper
• IL-3 inhibits rat osteoclast differentiation induced by TNF-α and other pro-osteoclastogenic cytokines

  2021cites this paper
• Cytokines and the pathogenesis of osteoporosis

  2021cites this paper
• Serum miR‐224, miR‐760, miR‐483‐5p, miR‐378 and miR‐375 as potential novel biomarkers in rheumatoid arthritis

  2021cites this paper
• Cytokines and Bone: Osteoimmunology.

  2020cites this paper
• Role of Interleukins on Physiological and Pathological Bone Resorption and Bone Formation: Effects by Cytokines in The IL-12 and IL-17 Families, and by IL-3, IL-32 and IL-34

  2020cites this paper
• Involvement of Noncoding RNAs in the Differentiation of Osteoclasts

  2020cites this paper
• IL-3 Differentially Regulates Membrane and Soluble RANKL in Osteoblasts through Metalloproteases and the JAK2/STAT5 Pathway and Improves the RANKL/OPG Ratio in Adult Mice

  2018cites this paper
• The role of IL‐3 in bone

  2018cites this paper
• Regulation of Osteoclast Differentiation by Cytokine Networks

  2018cites this paper
• Étude in vitro de la toxicité de l’uranium sur les cellules osseuses en vue de la recherche de nouveaux agents décorporants

  2018cites this paper
• Tumor Necrosis Factor Alpha Promotes Osteoclast Formation Via PI3K/Akt Pathway‐Mediated Blimp1 Expression Upregulation

  2017cites this paper
• The Effects of Immune Cell Products (Cytokines and Hematopoietic Cell Growth Factors) on Bone Cells

  2016cites this paper
• IL-3 Decreases Cartilage Degeneration by Downregulating Matrix Metalloproteinases and Reduces Joint Destruction in Osteoarthritic Mice

  2016cites this paper
• Predictive genetic markers of coagulation, inflammation and apoptosis in Perthes disease—Serbian experience

  2015cites this paper
• Regulation and dysregulation of tumor necrosis factor receptor-1.

  2014cites this paper
• Expression profiling of microRNAs in RAW264.7 cells treated with a combination of tumor necrosis factor alpha and RANKL during osteoclast differentiation.

  2013cites this paper
• Arthritisand Prevents Inflammatory -Induced Bone α IL-3 Inhibits TNF-

  2013cites this paper
• Interleukin-3 plays dual roles in osteoclastogenesis by promoting the development of osteoclast progenitors but inhibiting the osteoclastogenic process.

  2013cites this paper
• IL-3 promotes osteoblast differentiation and bone formation in human mesenchymal stem cells.

  2012cites this paper
• 7 – The Effects of Immune Cell Products (Cytokines and Hematopoietic Cell Growth Factors) on Bone Cells

  2011cites this paper
• IL-3 Attenuates Collagen-Induced Arthritis by Modulating the Development of Foxp3+ Regulatory T Cells

  2011cites this paper
• Regulatory T Cells + by Modulating the Development of Foxp 3 IL-3 Attenuates Collagen-Induced Arthritis and

  2011cites this paper
• Response to Comment on “IL-3 Attenuates Collagen-Induced Arthritis by Modulating the Development of Foxp3+ Regulatory T Cells”

  2011cites this paper
• Comment on “IL-3 Attenuates Collagen-Induced Arthritis by Modulating the Development of Foxp3+ Regulatory T Cells”

  2011cites this paper
• IL-3 Attenuates Collagen-Induced Arthritis

  2011cites this paper
• IL-3 Inhibits Human Osteoclastogenesis and Bone Resorption through Downregulation of c-Fms and Diverts the Cells to Dendritic Cell Lineage

  2010cites this paper
• Genetic and Environmental Factors Suggest that Dietary Fatty Acid Content, Lipid Metabolism, and Bone Properties are Key Regulators of Myeloid Progenitor Cell Frequency

  2010cites this paper
• Embracing novel cytokines in RA - complexity grows as does opportunity!

  2010cites this paper
• Lineage c-Fms and Diverts the Cells to Dendritic Cell Bone Resorption through Downregulation of IL-3 Inhibits Human Osteoclastogenesis and Pote

  2010cites this paper
• Irreversible inhibition of RANK expression as a possible mechanism for IL-3 inhibition of RANKL-induced osteoclastogenesis.

  2010cites this paper
• Osteoclast Differentiation and Function

  2009cites this paper
• IL-3 inhibits TNF-alpha-induced bone resorption and prevents inflammatory arthritis.

  2009cites this paper
• IL-3 Inhibits TNF-α-Induced Bone Resorption and Prevents Inflammatory Arthritis1

  2009cites this paper
• Ras / ERK Pathway theBone-Resorbing Osteoclasts by Activating of Mononuclear Osteoclasts into Colony-Stimulating Factor Regulates Fusion Granulocyte-Macrophage

  2009cites this paper
• GM-CSF Regulates Fusion of Mononuclear Osteoclasts into Bone-Resorbing Osteoclasts by Activating the Ras/ERK Pathway1

  2009cites this paper
• This information is current as by Activating the Ras / ERK Pathway Osteoclasts into Bone-Resorbing Osteoclasts GM-CSF Regulates Fusion of Mononuclear

  2009cites this paper
• Granulocyte-Macrophage Colony-Stimulating Factor Regulates Fusion of Mononuclear Osteoclasts into Bone-Resorbing Osteoclasts by Activating the Ras/ERK Pathway 1

  2009cites this paper
• Osteoclast precursors acquire sensitivity to breast cancer derived factors early in differentiation.

  2008cites this paper
• Inflammatory osteoclastogenesis can be induced by GM-CSF and activated under TNF immunity.

  2008cites this paper
• Osteoimmunology: cytokines and the skeletal system.

  2008cites this paper
• Osteoimmunology: interactions of the bone and immune system.

  2008cites this paper
• Cultured human periodontal ligament cells constitutively express multiple osteotropic cytokines and growth factors, several of which are responsive to mechanical deformation.

  2008cites this paper
• Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation

  2007cites this paper
• Role of NAD(P)H:quinone oxidoreductase 1 on tumor necrosis factor-alpha-induced migration of human vascular smooth muscle cells.

  2007cites this paper
• Gene Expression Profiling in Paget's Disease of Bone: Upregulation of Interferon Signaling Pathways in Pagetic Monocytes and Lymphocytes

  2007cites this paper
• Clinical and basic research papers – March 2005 selections

  2005cites this paper